Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_contact.jpg?itok=5vQYyaFF)
Vrbková Jana Ph.D.
Journals
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
Molecular Oncology.
2018,
12(4),
561-576,
ISSN: 1574-7891,
PMID: 29465803,
Toll-Like Receptor 7/8 Ligand, S28463, Suppresses Ascaris Suum Induced Allergic Asthma in Nonhuman Primates.
American Journal of Respiratory Cell and Molecular Biology.
2018,
58(1),
55-65,
ISSN: 1044-1549,
PMID: 28850259,